Keyoung Hansoo Michael bought KAPA
September 16, 2025 · Form 4 insider transaction
Keyoung Hansoo Michael bought 10,000 shares of Kairos Pharma, Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 71 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$0.00
Total value
N/A
InsiderKeyoung Hansoo Michael
Role—
CompanyKairos Pharma, Ltd. (KAPA)
SecurityCOMMON STOCK
Transaction codeA: Grant or award
Transaction dateSeptember 16, 2025
Filing dateNovember 26, 2025
Shares owned after10,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents 10,000 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan (the "Plan"). The 10,000 RSUs were granted on September 16, 2024, in conjunction with the Issuer's initial public offering (IPO), and grant in substantially equal installments on the anniversary date of the IPO.; Consists of (i) 3,334 shares of common stock and (ii) 6,666 RSUs which remain subject to vesting.